Ronald M. Kurtz M.D. is CEO & President at RxSight, Inc. (RXST). They have made 2 open-market trades across 1 company since 2021, most recently 2026-09-02.
CIK 0001295469
1 open-market purchase totalling $2.1M since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RXST | 71,775 | $324K |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXST | SELL | 2026-09-02 | 2026-09-02 | $6.96 | $35K | -20.5% | -33.5% | — |
| RXST | SELL · 10b5-1 | 2024-05-03 | 2024-05-06 | $60.15 | $2.4M | -6.4% | -11.9% | -38.7% |
| RXST | SELL · 10b5-1 | 2024-01-08 | 2024-01-09 | $44.25 | $2.8M | +2.9% | +6.3% | +22.3% |
| RXST | SELL · 10b5-1 | 2023-12-27 | 2023-12-29 | $41.09 | $1.8M | +19.2% | +21.7% | +30.8% |
| RXST | SELL · 10b5-1 | 2023-12-14 | 2023-12-18 | $39.71 | $1.6M | +2.4% | +15.7% | +18.8% |
| RXST | BUY | 2021-08-03 | 2021-08-05 | $15.88 | $2.1M | -14.4% | +14.4% | -6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.